<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Nutritional status and health-related quality of life in men with advanced castrate-resistant prostate cancer</dc:title><dc:creator>Čavka,	Luka	(Avtor)
	</dc:creator><dc:creator>Pohar Perme,	Maja	(Avtor)
	</dc:creator><dc:creator>Zakotnik,	Branko	(Avtor)
	</dc:creator><dc:creator>Rotovnik-Kozjek,	Nada	(Avtor)
	</dc:creator><dc:creator>Šeruga,	Boštjan	(Avtor)
	</dc:creator><dc:subject>prostate cancer</dc:subject><dc:subject>nutritional status</dc:subject><dc:subject>quality of life</dc:subject><dc:description>Despite professional recommendations malnutrition is not adequately addressed in cancer patients. Here, we explored whether nutritional status (NS) is associated with HRQoL in men with metastatic castrate-resistant prostate cancer (mCRPC). Methods: Men with mCRPC enrolled into this prospective observational study were allocated to one of the four NS categories based on clinical, laboratory, and patient self-reported criteria: well-nourished (WN), nutritional risk without criteria for cachexia/sarcopenia (NR), sarcopenia, and cachexia. The HRQoL was evaluated by the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire. Association between NS and self-reported HRQoL was sought by the linear regression model, which was adjusted for known prognostic variables and body mass index. Results: Over the period of two years, 141 patients were enrolled. Their median age was 74.1 years (IQR 68.6–79.4 years) and majority of them were minimally symptomatic. Fifty-nine patients (41.8%) were WN, followed by 24 (17%), 42 (29.8%), and 16 (11.4%) patients with NR, sarcopenia, and cachexia, respectively. As compared to WN patients, all three other NS categories were significant negative predictors of HRQoL (P&lt;0.04). Conclusions: Abnormal NS is highly prevalent in men with mCRPC and is negatively associated with their HRQoL, which supports the recommendation for management of malnutrition in these patients.</dc:description><dc:date>2022</dc:date><dc:date>2022-09-26 11:01:13</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>141228</dc:identifier><dc:identifier>UDK: 616-006</dc:identifier><dc:identifier>ISSN pri članku: 0163-5581</dc:identifier><dc:identifier>DOI: 10.1080/01635581.2021.1884731</dc:identifier><dc:identifier>COBISS_ID: 51943427</dc:identifier><dc:language>sl</dc:language></metadata>
